JP2023133432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023133432A5 JP2023133432A5 JP2023121862A JP2023121862A JP2023133432A5 JP 2023133432 A5 JP2023133432 A5 JP 2023133432A5 JP 2023121862 A JP2023121862 A JP 2023121862A JP 2023121862 A JP2023121862 A JP 2023121862A JP 2023133432 A5 JP2023133432 A5 JP 2023133432A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- hcvr
- lcvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662413198P | 2016-10-26 | 2016-10-26 | |
| US62/413,198 | 2016-10-26 | ||
| PCT/US2017/058555 WO2018081437A1 (en) | 2016-10-26 | 2017-10-26 | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody |
| JP2019522823A JP7374765B2 (ja) | 2016-10-26 | 2017-10-26 | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522823A Division JP7374765B2 (ja) | 2016-10-26 | 2017-10-26 | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023133432A JP2023133432A (ja) | 2023-09-22 |
| JP2023133432A5 true JP2023133432A5 (https=) | 2024-01-19 |
Family
ID=60570180
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522823A Active JP7374765B2 (ja) | 2016-10-26 | 2017-10-26 | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 |
| JP2023121862A Pending JP2023133432A (ja) | 2016-10-26 | 2023-07-26 | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522823A Active JP7374765B2 (ja) | 2016-10-26 | 2017-10-26 | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11267876B2 (https=) |
| EP (1) | EP3532099A1 (https=) |
| JP (2) | JP7374765B2 (https=) |
| KR (1) | KR102701695B1 (https=) |
| CN (1) | CN110114087A (https=) |
| AU (1) | AU2017347822B2 (https=) |
| BR (1) | BR112019008279A2 (https=) |
| CA (1) | CA3041325A1 (https=) |
| IL (1) | IL266199B2 (https=) |
| MA (1) | MA46673A (https=) |
| MX (1) | MX2019004940A (https=) |
| RU (1) | RU2019115946A (https=) |
| SG (1) | SG11201903602RA (https=) |
| WO (1) | WO2018081437A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102701695B1 (ko) | 2016-10-26 | 2024-08-30 | 리프 테라퓨틱스 인코포레이티드 | 항-dkk-1 항체를 사용하여 암을 치료하기 위한 바이오마커로서의 베타-카테닌의 용도 |
| CA3128526A1 (en) | 2019-02-01 | 2020-08-06 | Board Of Regents, The University Of Texas System | Monoclonal antibodies against mhc-bound human dickkopf-1 peptides and uses thereof |
| BR112022004851A2 (pt) * | 2019-09-19 | 2022-08-23 | Leap Therapeutics Inc | Uso de inibidores de dkk-1 para tratar câncer |
| EP4061419A1 (en) * | 2019-11-22 | 2022-09-28 | Leap Therapeutics, Inc. | Methods of treating cancer using dkk-1-inhibitors |
| EP4471056A4 (en) | 2022-01-28 | 2026-02-18 | Shanghai Junshi Biosciences Co Ltd | Anti-DKK1 antibodies, pharmaceutical composition and associated uses |
| US20250222062A1 (en) * | 2022-03-24 | 2025-07-10 | The Translational Genomics Research Institute | Peptide inhibitors targeting the tbl1-beta-catenin complex |
| CN116350758B (zh) * | 2023-03-16 | 2024-08-06 | 郑州大学 | 肿瘤共享新抗原表位肽或其编码核酸在制备药物中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US7446181B2 (en) * | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
| AR060017A1 (es) | 2006-01-13 | 2008-05-21 | Novartis Ag | Composiciones y metodos de uso para anticuerpos de dickkopf -1 |
| CN101641373B (zh) * | 2007-02-08 | 2015-02-11 | 默沙东公司 | Dkk-1的特异性抗体 |
| WO2009028158A1 (en) | 2007-08-24 | 2009-03-05 | Oncotherapy Science, Inc. | Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker |
| AR075989A1 (es) | 2009-04-10 | 2011-05-11 | Lilly Co Eli | Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria |
| CN102421798A (zh) | 2009-05-07 | 2012-04-18 | 诺瓦提斯公司 | 与dickkopf-1或dickkopf-4或两者的结合分子的组合物及使用方法 |
| CA2783665A1 (en) | 2010-03-03 | 2011-09-09 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| CN103608037B (zh) * | 2011-02-01 | 2016-04-13 | 香港大学 | 抗dkk1单克隆抗体用于治疗肝癌的用途 |
| ES2703208T3 (es) * | 2013-02-27 | 2019-03-07 | Daiichi Sankyo Co Ltd | Método de predicción de la sensibilidad a un compuesto que inhibe la vía de transducción de señales de MAPK |
| TW201610168A (zh) * | 2013-12-02 | 2016-03-16 | 安可美德藥物股份有限公司 | 與Ｗｎｔ途徑抑制劑有關之預測性生物標記之鑑別 |
| KR102701695B1 (ko) | 2016-10-26 | 2024-08-30 | 리프 테라퓨틱스 인코포레이티드 | 항-dkk-1 항체를 사용하여 암을 치료하기 위한 바이오마커로서의 베타-카테닌의 용도 |
| BR112022004851A2 (pt) | 2019-09-19 | 2022-08-23 | Leap Therapeutics Inc | Uso de inibidores de dkk-1 para tratar câncer |
| EP4061419A1 (en) | 2019-11-22 | 2022-09-28 | Leap Therapeutics, Inc. | Methods of treating cancer using dkk-1-inhibitors |
| WO2023039249A1 (en) | 2021-09-10 | 2023-03-16 | Leap Therapeutics, Inc. | Combination therapy |
| KR20250057775A (ko) | 2022-07-12 | 2025-04-29 | 리프 테라퓨틱스 인코포레이티드 | 조합 요법 |
-
2017
- 2017-10-26 KR KR1020197014600A patent/KR102701695B1/ko active Active
- 2017-10-26 WO PCT/US2017/058555 patent/WO2018081437A1/en not_active Ceased
- 2017-10-26 CA CA3041325A patent/CA3041325A1/en active Pending
- 2017-10-26 IL IL266199A patent/IL266199B2/en unknown
- 2017-10-26 AU AU2017347822A patent/AU2017347822B2/en active Active
- 2017-10-26 SG SG11201903602RA patent/SG11201903602RA/en unknown
- 2017-10-26 MX MX2019004940A patent/MX2019004940A/es unknown
- 2017-10-26 CN CN201780071597.0A patent/CN110114087A/zh active Pending
- 2017-10-26 MA MA046673A patent/MA46673A/fr unknown
- 2017-10-26 US US16/345,191 patent/US11267876B2/en active Active
- 2017-10-26 JP JP2019522823A patent/JP7374765B2/ja active Active
- 2017-10-26 BR BR112019008279-4A patent/BR112019008279A2/pt active Search and Examination
- 2017-10-26 RU RU2019115946A patent/RU2019115946A/ru unknown
- 2017-10-26 EP EP17808633.6A patent/EP3532099A1/en active Pending
-
2022
- 2022-01-28 US US17/587,708 patent/US12319730B2/en active Active
-
2023
- 2023-07-26 JP JP2023121862A patent/JP2023133432A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023133432A5 (https=) | ||
| JP2021527431A5 (https=) | ||
| US9469688B2 (en) | Therapeutic DLL4 binding proteins | |
| JP5964249B2 (ja) | 治療用ｄｌｌ４結合タンパク質 | |
| JP2021524256A5 (https=) | ||
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| JP2021524244A5 (https=) | ||
| JP2021513540A5 (https=) | ||
| RU2019115946A (ru) | Применение бета-катенина в качестве биомаркера для лечения форм рака с помощью антитела к dkk-1 | |
| JP2021527640A5 (https=) | ||
| JP2009532336A5 (https=) | ||
| JP2018506277A5 (https=) | ||
| RU2018119165A (ru) | Антитело против лиганда 1 запрограммированной гибели клеток (pd-l1), его антигенсвязывающий фрагмент и их медицинское применение | |
| ME02371B (me) | Sastojci i postupci za dijagnstikovanje i tretman raka | |
| JP2018510617A5 (https=) | ||
| JP2021510736A5 (https=) | ||
| JP2012532851A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| JPWO2021139777A5 (https=) | ||
| JP2013508292A5 (https=) | ||
| JP2021520393A5 (https=) | ||
| JP2021512652A5 (https=) | ||
| JP2020533965A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JPWO2019223733A5 (https=) |